octimibate has been researched along with Atherosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chern, CY; Lien, CF; Lin, CS; Lin, FY; Tsai, CS; Tsai, MC; Tsui, PF | 1 |
1 other study(ies) available for octimibate and Atherosclerosis
| Article | Year |
|---|---|
An octimibate derivative, Oxa17, enhances cholesterol efflux and exerts anti-inflammatory and atheroprotective effects in experimental atherosclerosis.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Cholesterol; Diet, High-Fat; Dose-Response Relationship, Drug; Humans; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; THP-1 Cells | 2021 |